Aileron Therapeutics Inc.

09/23/2024 | Press release | Distributed by Public on 09/23/2024 05:57

Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)